TD Waterhouse Canada’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

TD Waterhouse Canada’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412	Hold	625	–	–	﹤0.01%	2257
2026 Q1	$498	Hold	625	–	–	﹤0.01%	2152
2025 Q4	$3.46K	Hold	625	–	–	﹤0.01%	1753
2025 Q3	$4.53K	Hold	625	–	–	﹤0.01%	1713
2025 Q2	$4.6K	Buy	625 +600	+2,400%	+$9.35K	﹤0.01%	1613
2025 Q1	$306	Buy	+25	New	+$786	﹤0.01%	1826

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

TD Waterhouse Canada's RVPH Position: Q2 2026 in Review

TD Waterhouse Canada held its REVIVA PHARMA HLDGS INC (RVPH) position steady in Q2 2026 at 625 shares worth $412. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

TD Waterhouse Canada first reported a position in RVPH in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.6K in Q2 2025. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

TD Waterhouse Canada held 625 shares of REVIVA PHARMA HLDGS INC worth $412 as of Q2 2026.
TD Waterhouse Canada left its REVIVA PHARMA HLDGS INC share count unchanged in Q2 2026.
REVIVA PHARMA HLDGS INC made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2257 holding.
TD Waterhouse Canada first reported a position in REVIVA PHARMA HLDGS INC in Q1 2025 and has held it in 6 quarters since.
TD Waterhouse Canada's REVIVA PHARMA HLDGS INC position peaked at $4.6K in Q2 2025.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.